Chamber and committees

The COVID-19 Scientific Advisory Sub-Group on Education and Children’s Issues published a summary report of the evidence on children, schools, early learning and childcare settings and transmission from COVID-19 on 12 August 2021. This included a brief summary of available evidence on Long-COVID in children and young people , along with a list of references to relevant evidence which may also be of interest. Public Health Scotland also provide a regular review of evidence for the sub-group in relation to COVID-19 and children and young people.

The Sub-Group continues to review the evidence on acute and prolonged health effects of COVID-19, and will update their advice if required in light of new findings.

In addition, the UK wide clinical guideline on managing the long-term effects of COVID-19 produced by the National Institute for Health and Care Excellence (NICE), the Scottish Intercollegiate Guidelines Network (SIGN) and the Royal College of General Practitioners (RCGP) is continuously reviewed and updated in response to emerging evidence.

For the November 2021 update, the evidence for children and young people was reviewed. A full overview of this evidence reviewed can be found on page 37 of the clinical guideline, accessible at Guideline COVID-19 rapid guideline: managing the long-term effects of COVID-19 (nice.org.uk)

The Scottish Government Reducing Risks in Schools guidance contains a range of mitigations, such as use of face coverings, distancing requirements in schools and on school transport, and guidance for visitors and in-school events. This guidance is currently under active review, with input this week from the COVID-19 Education Recovery Group and the Advisory Sub-Group on Education and Children's Issues . A new version will be published this week. The guidance will remain under regular review and, where the scientific advice supports it, mitigations will be enhanced or removed as appropriate.

he Scottish Government’s Chief Scientist Office has funded nine research projects designed to improve our understanding of the longer term effects of the COVID-19 infection, or long COVID. Three projects focus on the prevalence and symptoms of long COVID. All started in early 2021 and will run for two years.

LTE2015.pdf (scot.nhs.uk) ‘Developing and validating a risk prediction model for long COVID-19’. Undertaken by the University of Edinburgh, in collaboration with Public Health Scotland, this research builds on the EAVE II study, originally funded by the Medical Research Council ( An Introduction to EAVE II | The University of Edinburgh ). EAVE II has used a pseudonymised patient dataset to track the COVID-19 pandemic as it unfolded across Scotland. This dataset will now be used to develop a model which will identify people at greatest risk of developing long COVID. In the course of developing that model, the research will generate data about the number of people in Scotland diagnosed with long COVID and their use of health services. This project will cover the population as a whole, including children.

lte2006.pdf (scot.nhs.uk) ‘Defining and understanding the longer-term effects of COVID-19: a mixed methods study exploring the frequency, nature, and impact of ‘long COVID’ in the Scottish population’. Undertaken by the university of Glasgow, this study will identify how many people continue to be unwell, their symptoms, and how it affects their lives. Scottish adults who had a positive COVID-19 test, and a negative test comparison group, will be sent an SMS message inviting them to take part in the study. If they agree, they will answer questions about their health before and after COVID-19, and any effect on their lives, with the questions repeated at regular intervals. This project will cover people aged 16+.

LTE2008.pdf (scot.nhs.uk) ‘COVID-19: Tracking Persistent Symptoms in Scotland (TraPSS)’ – undertaken by the University of the West of Scotland. This project aims toimprove our understanding of long COVID in the Scottish population, and particularly in people whose original symptoms were relatively mild. The current evidence describing the types of symptoms other studies have reported will be reviewed, and people will be surveyed at different stages of recovery to find out what kinds of persistent symptoms they have. The project will survey adults aged 18+.

Currently the best source of estimated long COVID prevalence data for Scotland is the monthly Office for National Statistics (ONS) reporting on ‘Estimates of the prevalence of self-reported long COVID and associated activity limitation, using UK Coronavirus (COVID-19) Infection Survey data’.The most recent report is here.

Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK - Office for National Statistics (ons.gov.uk) This showed that, over the four-week period ending 31 October 2021, an estimated 99,000 people (95% confidence interval: 89,000 to 109,000) in the private residential population in Scotland (1.87%; 95% CI: 1.68% to 2.07%) reported experiencing long COVID of any duration. Detailed estimates by age group and symptoms are available for the UK, but this detail is not available for Scotland.

We have always been clear from the outset, that the funding provided in 2021-22 would be for 1 year only.

This was funded from the Covid consequentials afforded to us by the UK Government. The scheme was designed to help public bodies, local authorities and communities prepare for the 2021 season and provided some seed funding to support rangers and temporary infrastructure. It was necessary given the challenges faced in 2020 with little international travel opportunities and a large desire for domestic countryside visits.

The fund was extremely successful. A list of successful awards can be found here: Better Places Green Recovery Fund - Successful Projects | NatureScot

Going forward however, we continue to focus on long term solutions. For example, to date our Rural Tourism Infrastructure Fund is supporting projects across the country to the tune of £15m. This includes permanent infrastructure such as car parks, toilets and waste disposal facilities, each with a 10 year minimum life span. We plan to continue this fund into 2022-23.

The work of the Visitor Management Steering Group will also continue. For more information please see: https://www.visitscotland.org/about-us/what-we-do/working-in-partnership/visitor-management-plan .

As advised in response to the question S6W-03892, the booster vaccination programme is administered by health boards and GP practices. NHS health board costs across Scotland will vary depending on their location, cost structures, and local delivery mechanisms.

The Scottish Government is conscious of demonstrating value for the public pound and to this extent, it costs £12.58 per vaccination dose (whether first, second, third or booster) when administered by GP practices.

The licensing of medicines is reserved to the UK Government, and is the responsibility of the Medicines and Healthcare products Regulatory Agency (MHRA). The Scottish Government has no formal powers in this area.

The Scottish Government provides baseline funding to NHS Boards and it is for Boards to determine how to use this funding to meet the healthcare needs of their resident population.

In 2021-22, Health funding exceeds £16 billion with £11.6 billion allocated to our frontline Health Boards, and a further £1.9 billion to address pressures relating to Covid-19 across health and social care.

Detail on how funding has been used specifically for the assessment and treatment of deep vein thrombosis would require to be requested from NHS Boards.

As a result of the Covid-19 pandemic, Ministers agreed to move the date of Scotland’s Census from March 2021 to March 2022. This decision was taken to address significant pandemic risks to the successful completion of the census and to the delivery of the benefits required by the people of Scotland.

The impact of an extra year adds to the programme lifecycle cost, with the major financial implications of the move to 2022 being:

• The cost of extending suppliers contracts; and
• The programme’s headcount being maintained for an extra year.

National Records of Scotland (NRS) undertook significant engagement with the multiple census suppliers, with initial and final repricing exercises, interrogation of costs and an extensive resource planning exercise. This work assessed estimated additional costs of up to £21.6m for the delivery of Scotland’s Census in 2022 across the remaining lifecycle of the programme.

NRS continues to deliver against the revised plan with arrangements for Scotland’s Census 2022 well advanced.

Most people were able to access the NHS Scotland Covid Status App without difficulty from launch. Where people experienced difficulties it was when they requested access to their vaccination status through the app after having verified their identity. This process involved the app linking to an existing NHS system. There was an extremely high number of initial users trying to access this NHS system that matched a verified an individual with their health record at the same time. This led to the system being overwhelmed for a short period and a related fault developing in the NHS system that routed these requests. The fault, along with the required fix, was identified within the first 24 hours and the fix successfully implemented on the evening of 1 October. The backlog of health record matching requests had been cleared within 48 hours of the app being launched, during which time people who experienced difficulties at that time could continue to use their paper version, or their PDF downloaded copy.

Booster vaccinations in Scotland started as soon as possible once the Joint Committee on Vaccination and Immunisation (JCVI) provided their advice on boosters. In response to the changing risk posed by the Omicron variant, the booster will now be given no sooner than 3 months after the primary course.

1,961,588 people have received a booster or 3rd dose to 8 December, and we are working as quickly as we can, prioritising those most vulnerable.

Data is published at COVID-19 Daily Dashboard | Tableau Public which includes boosters and 3rd doses delivered per JCVI cohort.

We continue to work closely with Public Health Scotland to develop the vaccination data to provide robust statistics that enhance public understanding.

While demographic difference make robust comparisons difficult, figures from the UK dashboard show we have administered boosters or 3rd doses to a greater proportion of the population than the other UK nations at this stage of the programme.

We are aiming to offer the booster vaccine to everyone aged 18 or older who is eligible by the end of January 2022.